U
ETRM

UBS’s EnteroMedics Inc. ETRM Stock Holding History

UBS’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$10K Buy
8
+6
+300% +$8.79K ﹤0.01% 8898
2014
Q2 		$3K Sell
2
-8
-80% -$15K ﹤0.01% 9981
2014
Q1 		$19K Buy
+10
New +$23.7K ﹤0.01% 8213

Other funds holding ETRM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

UBS's ETRM Position: Q3 2014 in Review

UBS reduced its EnteroMedics Inc. (ETRM) stake by 96% in Q3 2014, selling an estimated $68.9K and leaving 2 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #10121.

UBS first reported a position in ETRM in Q2 2013 and has held it in 4 quarters since. The position peaked at $80K in Q2 2014. 49 funds tracked by Wall St. Rank hold ETRM as of Q3 2014.

  • UBS held 2 shares of EnteroMedics Inc. worth $2K as of Q3 2014.
  • UBS sold 47 EnteroMedics Inc. shares in Q3 2014, an estimated $68.9K.
  • EnteroMedics Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10121 holding.
  • UBS first reported a position in EnteroMedics Inc. in Q2 2013 and has held it in 4 quarters since.
  • UBS's EnteroMedics Inc. position peaked at $80K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.